Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin plus Chloroquine for Uncomplicated Falciparum Malaria
NCT00084240Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Mar 2004
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of azithromycin in Malaria, sponsored by Pfizer. Started Mar 2004; status: terminated.
02
Drugs
azithromycin
03
Conditions
Malaria
Beyond the preview
Go deeper on NCT00084240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00084240.